Drug
Atb200
Atb200: highest development phase Phase 1/2, developed by Amicus Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ATB200 NCT02675465 | Phase 1/2 | Pompe Disease |
Latest
No recent events.
Follow Atb200 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.